Home

Úměrný Klasifikovat odložit nf kappa b inhibitor ppar agonist nejlépe tkanina Největší

The peroxisome proliferator-activated receptor γ agonist pioglitazone  prevents NF-κB activation in cisplatin nephrotoxicity through the reduction  of p65 acetylation via the AMPK-SIRT1/p300 pathway - ScienceDirect
The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway - ScienceDirect

Molecular mechanisms of PPAR transrepression pathways. (a-b)... | Download  Scientific Diagram
Molecular mechanisms of PPAR transrepression pathways. (a-b)... | Download Scientific Diagram

Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases  by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology

Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental  Targeting for the Treatment of Inflammatory Bowel Diseases
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

IJMS | Free Full-Text | The Role of PPAR Alpha in the Modulation of Innate  Immunity
IJMS | Free Full-Text | The Role of PPAR Alpha in the Modulation of Innate Immunity

PPAR Inhibition | PPAR Agonist Review
PPAR Inhibition | PPAR Agonist Review

Cells | Free Full-Text | PPAR-Mediated Toxicology and Applied Pharmacology
Cells | Free Full-Text | PPAR-Mediated Toxicology and Applied Pharmacology

IJMS | Free Full-Text | Role of NF-κB in Platelet Function
IJMS | Free Full-Text | Role of NF-κB in Platelet Function

NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy

Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ  of rat brain astrocytes in the course of activation by toll‐like receptor  agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online  Library
Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ of rat brain astrocytes in the course of activation by toll‐like receptor agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online Library

Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma  and Atherosclerosis: Post-translational Modification and Selective  Modulators
Frontiers | The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators

Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway  inhibition - ScienceDirect
Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition - ScienceDirect

Frontiers | PPAR-α Modulators as Current and Potential Cancer Treatments
Frontiers | PPAR-α Modulators as Current and Potential Cancer Treatments

Molecules | Free Full-Text | Is There a Future for PPARs in the Treatment  of Neuropsychiatric Disorders?
Molecules | Free Full-Text | Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?

A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons  from GR and PPARs
A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs

Cross-talk of PPARγ with other signaling pathways, such as nuclear... |  Download Scientific Diagram
Cross-talk of PPARγ with other signaling pathways, such as nuclear... | Download Scientific Diagram

Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments
Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments

Therapeutic potential of PPARγ natural agonists in liver diseases - Wu -  2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Therapeutic potential of PPARγ natural agonists in liver diseases - Wu - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library

Frontiers | The Protective Effects of Peroxisome Proliferator-Activated  Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
Frontiers | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury

Activation of peroxisome proliferator‐activated receptor delta suppresses  BACE1 expression by up‐regulating SOCS1 in a JAK2/STAT1‐dependent manner -  Lee - 2019 - Journal of Neurochemistry - Wiley Online Library
Activation of peroxisome proliferator‐activated receptor delta suppresses BACE1 expression by up‐regulating SOCS1 in a JAK2/STAT1‐dependent manner - Lee - 2019 - Journal of Neurochemistry - Wiley Online Library

PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation -  ScienceDirect
PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation - ScienceDirect

Regulation of NF-κB pathway by PPAR agonists in CNS diseases. The... |  Download Scientific Diagram
Regulation of NF-κB pathway by PPAR agonists in CNS diseases. The... | Download Scientific Diagram

Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB /Nrf-2/PPAR-γ interplay in mice - ScienceDirect
Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB /Nrf-2/PPAR-γ interplay in mice - ScienceDirect

Frontiers | Crosstalk Between Peroxisome Proliferator-Activated Receptor  Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and  Oxidative Stress During Carcinogenesis
Frontiers | Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis

Figure 4 | AMPK-Dependent Metabolic Regulation by PPAR Agonists
Figure 4 | AMPK-Dependent Metabolic Regulation by PPAR Agonists

PPARα agonist and metformin co-treatment ameliorates NASH in mice induced  by a choline-deficient, amino acid-defined diet with 45% fat | Scientific  Reports
PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat | Scientific Reports